The achievements of stimulating the immune system to prevent disease have been profound, saving millions from sickness and death. Inovio is advancing breakthroughs to extend this legacy to not only prevent many of today’s challenging diseases, but also treat them. Our DNA immunotherapies activate the body’s immune system to break the body’s tolerance of cancerous cells and protect against diverse, changing strains of infectious diseases.

Inovio is revolutionizing the fight against cancers and infectious diseases! NASDAQ: INO

Our Partnerships View All

Inovio’s DNA immunotherapies and delivery technology have attracted pharma companies, government agencies, universities and foundations.
  •       Logo - Homepage MedImmune
  • Logo: Merck
  •                  Logo: University of Pennsylvania